Exploring anti-malarial potential of FDA approved drugs: an in silico approach

BACKGROUND: The critically important issue on emergence of drug-resistant malarial parasites is compounded by cross resistance, where resistance to one drug confers resistance to other chemically similar drugs or those that share mode of action. This aspect requires discovery of new anti-malarial co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishnan, Gayatri, Chandra, Nagasuma, Srinivasan, Narayanaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516367/
https://www.ncbi.nlm.nih.gov/pubmed/28720135
http://dx.doi.org/10.1186/s12936-017-1937-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516367/
https://www.ncbi.nlm.nih.gov/pubmed/28720135
http://dx.doi.org/10.1186/s12936-017-1937-2

Ejemplares similares